作者：
Loriot, Yohann [1]
;
Miller, Kurt [2]
;
Sternberg, Cora N. [3]
;
Fizazi, Karim [4]
;
De Bono, Johann S. [5]
;
Chowdhury, Simon [6]
;
Higano, Celestia S. [7]
;
Noonberg, Sarah [8]
;
Holmstrom, Stefan [9]
;
Mansbach, Harry [10]
;
Perabo, Frank G. [11]
;
Phung, De [12]
;
Ivanescu, Cristina [13]
;
Skaltsa, Konstantina [14]
;
Beer, Tomasz M. ;
Tombal, Bertrand
作者单位：
Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, F-94800 Villejuif, France
[1]
Royal Marsden Hosp, Drug Dev Unit, London SW3 6JJ, England
[2]
Quintiles, Consulting, Hoofddorp, Netherlands
[3]
Medivation, Dept Early Clin Dev, San Francisco, CA USA
[4]
Astellas Pharma Europe, Hlth Econ & Outcomes Res, Leiden, Netherlands
[5]
Clin Univ St Luc, Dept Urol, B-1200 Brussels, Belgium
[6]
San Camillo & Forlanini Hosp, Dept Med Oncol, Rome, Italy
[7]
Astellas Pharma Global Dev, Northbrook, IL USA
[8]
Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA
[9]
Quintiles, Consulting, Barcelona, Spain
[10]
Charite, Dept Urol, D-13353 Berlin, Germany
[11]
Univ Washington, Fred Hutchinson Canc Res Ctr, Div Med Oncol, Dept Med, Seattle, WA 98195 USA
[12]
Medivation, Dept Med Affaires, San Francisco, CA USA
[13]
Guys & St Thomas Hosp, Dept Urol, London SE1 9RT, England
[14]
发布时间
2015-07-17
换一批
换一批
